158 related articles for article (PubMed ID: 33938630)
1. Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis.
Salomone F; Currenti W; Magrì G; Boškoski I; Zelber-Sagi S; Galvano F
Liver Int; 2021 Sep; 41(9):2112-2116. PubMed ID: 33938630
[TBL] [Abstract][Full Text] [Related]
2. Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months.
Vijayaraghavan R; Sarin SK; Bharadwaj A; Anand L; Maiwall R; Choudhury A; Benjamin J; Kanal U; Jamwal KD
Dig Dis Sci; 2023 Mar; 68(3):1035-1041. PubMed ID: 35763235
[TBL] [Abstract][Full Text] [Related]
3. Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis.
Bazerbachi F; Vargas EJ; Rizk M; Maselli DB; Mounajjed T; Venkatesh SK; Watt KD; Port JD; Basu R; Acosta A; Hanouneh I; Gara N; Shah M; Mundi M; Clark M; Grothe K; Storm AC; Levy MJ; Abu Dayyeh BK
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):146-154.e4. PubMed ID: 32360804
[TBL] [Abstract][Full Text] [Related]
4. Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease.
van Dijk AM; de Vries M; El-Morabit F; Bac ST; Mundt MW; van der Schuit LE; Hirdes MMC; Kara M; de Bruijne J; van Meer S; Kaasjager HAH; de Valk HW; Vleggaar FP; van Erpecum KJ
Intern Emerg Med; 2023 Nov; 18(8):2271-2280. PubMed ID: 37700180
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis.
Chandan S; Mohan BP; Khan SR; Facciorusso A; Ramai D; Kassab LL; Bhogal N; Asokkumar R; Lopez-Nava G; McDonough S; Adler DG
Obes Surg; 2021 Mar; 31(3):1271-1279. PubMed ID: 33409973
[TBL] [Abstract][Full Text] [Related]
6. Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis.
Popov VB; Thompson CC; Kumar N; Ciarleglio MM; Deng Y; Laine L
Dig Dis Sci; 2016 Sep; 61(9):2477-87. PubMed ID: 27207181
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: Impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity.
Aoko O; Maharaj T; Boland F; Cheriyan D; Ryan J
Aliment Pharmacol Ther; 2024 Jan; 59(1):8-22. PubMed ID: 37986213
[TBL] [Abstract][Full Text] [Related]
8. Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss.
Agnihotri A; Xie A; Bartalos C; Kushnir V; Sullivan S; Islam S; Islam E; Lamet M; Lamet A; Farboudmanesch R; Overholt BF; Altawil J; Early DS; Bennett M; Lowe A; Mullady DK; Adeyeri CS; El Zein M; Mishra P; Fayad L; Dunlap M; Oberbach A; Cheskin LJ; Kalloo AN; Khashab MA; Kumbhari V
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1081-1088.e1. PubMed ID: 29481969
[TBL] [Abstract][Full Text] [Related]
9. Non-obese patients with nonalcoholic fatty liver disease may use a lower liver stiffness cut-off to assess fibrosis stages.
Shi YW; Wang QY; Zhao XY; Sun YM; Kong YY; Ou XJ; Jia JD; Wu SS; You H
J Dig Dis; 2020 May; 21(5):279-286. PubMed ID: 32336033
[TBL] [Abstract][Full Text] [Related]
10. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
11. Comparative Study of Intragastric Balloon and Cognitive-Behavioral Approach for Non-Morbid Obesity.
Majanovic SK; Ruzic A; Bulian AP; Licul V; Orlic ZC; Stimac D
Hepatogastroenterology; 2014 Jun; 61(132):937-41. PubMed ID: 26158145
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety.
Fayad L; Cheskin LJ; Adam A; Badurdeen DS; Hill C; Agnihotri A; Dunlap M; Simsek C; Khashab MA; Kalloo AN; Kumbhari V
Endoscopy; 2019 Jun; 51(6):532-539. PubMed ID: 30841009
[TBL] [Abstract][Full Text] [Related]
13. Intragastric Balloon for Overweight Patients.
Martins Fernandes FA; Carvalho GL; Lima DL; Rao P; Shadduck PP; Montandon ID; de Souza Barros J; Rodrigues IL
JSLS; 2016; 20(1):. PubMed ID: 26955259
[TBL] [Abstract][Full Text] [Related]
14. Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre.
Nguyen V; Li J; Gan J; Cordero P; Ray S; Solis-Cuevas A; Khatib M; Oben JA
Can J Gastroenterol Hepatol; 2017; 2017():4697194. PubMed ID: 29441342
[TBL] [Abstract][Full Text] [Related]
15. Intragastric Balloon Treatment for Obesity: Review of Recent Studies.
Tate CM; Geliebter A
Adv Ther; 2017 Aug; 34(8):1859-1875. PubMed ID: 28707286
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
[TBL] [Abstract][Full Text] [Related]
17. When the liver gets stiff, the tough get moving.
Nguyen TH; Wardell R; Chitturi S; Teoh N; Farrell G
J Gastroenterol Hepatol; 2020 Jun; 35(6):953-959. PubMed ID: 31867782
[TBL] [Abstract][Full Text] [Related]
18. Outcomes with Intra-gastric Balloon Therapy in BMI < 35 Non-morbid Obesity: 10-Year Follow-Up Study of an RCT.
Chan DL; Cruz JR; Mui WL; Wong SKH; Ng EKW
Obes Surg; 2021 Feb; 31(2):781-786. PubMed ID: 33034015
[TBL] [Abstract][Full Text] [Related]
19. The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis.
Alkharaiji M; Anyanwagu U; Crabtree T; Idris I
Surg Obes Relat Dis; 2021 Apr; 17(4):792-798. PubMed ID: 33676874
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Efficacy and Safety of the FDA-approved Intragastric Balloon Systems in a Clinical Setting.
Swei E; Almuhaidb A; Sullivan S; Al-Shahrani A; D'Souza FR; Altayar O; Bell S; Maday R; Wagh MS; Mullady D; Bennett M; Early D; Kushnir V
J Clin Gastroenterol; 2023 Jul; 57(6):578-585. PubMed ID: 35604348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
